510(k) K260551
K260551 is an FDA 510(k) premarket notification submitted by Instrumentation Laboratory (IL) Co. for the device "HemosIL Factor V Leiden (APC Resistance V)". The FDA issued a decision of Substantially Equivalent on March 20, 2026. The device falls under product code GGW (Test, Time, Partial Thromboplastin), a Class II device regulated under 21 CFR 864.7925. Instrumentation Laboratory (IL) Co. has at least 4 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 20, 2026
- Date Received
- February 18, 2026
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Test, Time, Partial Thromboplastin
- Device Class
- Class II
- Regulation Number
- 864.7925
- Review Panel
- HE
- Submission Type